Cite

HARVARD Citation

    Gibney, G. et al. (n.d.). 511 Updated results from a phase 1/2 study of epacadostat (INCB024360) in combination with ipilimumab in patients with metastatic melanoma. European journal of cancer. pp. S106-S107. [Online]. 
  
Back to record